Dr. Christina Eschenfelder

Partner, Sustainability Reporting Advisor (EBS)

Dr. Christina Eschenfelder advises listed and unlisted companies and their supervisory board and managing board members primarily on stock corporation and corporate law as well as matters pertaining to corporate governance. Christina Eschenfelder provides guidance to investors and corporations during financing processes and advises nationally as well as internationally operating companies on structuring and restructuring measures as well as during Mergers & Acquisitions. Among other things, she has specialised in impact investing. Christina Eschenfelder is a lecturer in Corporate Governance in the Sustainable Finance post-graduate program at the EBS Executive School of the EBS Universität für Wirtschaft und Recht gGmbH.

Practice areas

Corporate law, especially stock corporation and capital markets law as well as the structuring and restructuring of medium-sized and listed companies
Guidance for supervisory board and managing board members in matters pertaining to stock corporation and corporate law as well as corporate governance
Mergers & Acquisitions as well as management of private equity funding and initial public offerings
Impact Investing

Vita

1997 Internship at the League of Arab States in London
2000 Legal work at the United Nations Institute for Training and Research (UNITAR) in Geneva
2001/2002 External staff member of the World Economic Forum (WEF), working at the World Economic Forum Annual Meeting in Davos and the European Economic Summit in Salzburg
1997 - 2003 Law studies in Würzburg, Geneva and Heidelberg
2005 Admitted to the German bar
2012 Partner of RITTERSHAUS law firm
2016 PhD (Dr. iur.) at Julius Maximilian University of Würzburg
2024 Acquisition of the additional qualification "Sustainability Reporting Advisor (EBS)"

Other activities and memberships

Lecturer for Corporate Governance in the compact study programme Sustainable Finance and Sustainability Reporting at the EBS Executive School of EBS Universität für Wirtschaft und Recht gGmbH
Member of the Sustainability Committee of the IHK Frankfurt am Main
Member of Working Moms Rhine-Neckar
Member of BPW (Business and Professional Women), Mannheim-Ludwigshafen
Member of the Gesellschaftsrechtliche Vereinigung - Wissenschaftliche Vereinigung für Unternehmens- und Gesellschaftsrecht (VGR) e. V., Frankfurt am Main (Corporate Law Association – Academic Association for Business and Corporate Law)
Member of FidAR e.V. - Women on Supervisory Boards e.V.

Specialised publications

„Erfolgsgarant für den Mittelstand“ - Artikel zu Corporate Governance in Mittelstand - Ausgabe 3/2024
„Transformation finanzieren“ - Interviewbeitrag in IHK WirtschaftsFORUM zum Focusthema Sustainable Finance – Ausgabe 08/09.2024
„Der Schlüssel zur verantwortungsvollen Unternehmensführung“ - Artikel zu Corporate Governance in wir.unternehmen, Ausgabe 3/2024
"Sustainable Corporate Governance ist immer individuell", Interview springerprofessional.de, März 2023
Sustainable Corporate Governance – Aktienrechtliche Grundlagen einer nachhaltigen Unternehmensführung, Springer Gabler 2022 (gemeinsam mit Jens Magers und Leo Krause-Wichmann)
Rechtsnachfolge in die Kommanditistenhaftung – Zur Rechtsnachfolge in die unbeschränkte Kommanditistenhaftung aufgrund rechtsgeschäftlicher Übertragung von Kommanditanteilen, Schriftenreihe zum deutschen und europäischen Gesellschafts- und Wirtschaftsrecht, Herausgegeben von Christoph Teichmann, Peter Lang Verlag 2015

Selected mandates

Advising HORNBACH Baumarkt AG on the purchase of Seniovo
Advising BWK Unternehmensbeteiligungsgesellschaft on the sale of its shares in R-Biopharm
Advising dievini Hopp BioTech holding GmbH & Co. KG in connection with Huadong's investment in Heidelberg Pharma AG
Advising CureVac AG during its IPO on the NASDAQ
Advising dievini Hopp BioTech GmbH & Co. KG on PIPE Investment in Immatics and merger of Immatics with Arya and listing on NASDAQ
Advising CureVac AG in a private financing round of around 560 million euros
Advising CureVac AG on the acquisition of Genmab
Advising Heidelberg Pharma on participation in German-French joint venture
Advising Novaliq GmbH during its funding round in October 2018 to raise €45 million
Advising Molecular Health GmbH during its funding round in May 2018 to raise €21 million
Advising CureVac AG on the involvement of Ely Lilli contributing equity investment to the tune of €45 million in December 2017
Advising Heidelberg Pharma AG and assisting the company during its funding round in November 2017 involving a mixed capital increase based on the distribution of shares in exchange for cash and non-cash contributions and issuing convertible bonds with an overall volume of €34,4 million
Advising Molecular Health GmbH during its funding round in August 2017 to raise €43 million
Advising Molecular Health GmbH during its funding round in April 2016 to raise € 37.5 million
Advising CureVac AG on the involvement of the Bill & Melinda Gates Foundation in 2015 as well as on its two funding rounds at the end of 2015 and in November 2016 to raise €26.5 million and €100 million, respectively
Advising a group under Italian control on the Europe-wide establishment of Cash Pool Systems
Advising public limited companies on the structuring of share option programmes and virtual stock ownership programmes
Assisting public limited companies with court proceedings following squeeze-outs
Advising dievini on the acquisition of LTS Lohmann Therapie Systeme AG
Advising Agennix AG on capital increase

My motto

“He who wants something, finds a way. He who doesn’t, finds a reason.” (Götz W. Werner)